Overview
Malgorzata Rajtar practices practicing medicine in Warsaw, Poland.
Ms. Rajtar is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Rhabdomyolysis, Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, and Mitochondrial Trifunctional Protein Deficiency.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Malgorzata Rajtar
Is Malgorzata Rajtar a top-rated expert for Rhabdomyolysis?
MediFind is an objective health platform that identifies experts based on real-world data. Malgorzata Rajtar is classified as an Advanced expert for Rhabdomyolysis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Malgorzata Rajtar participate in research or clinical trials?
Yes. Malgorzata Rajtar has published 8 articles and abstracts on conditions like Rhabdomyolysis. You can view a list of Malgorzata Rajtar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- RhabdomyolysisMs. Rajtar isAdvanced. Learn about Rhabdomyolysis.
- Experienced
- Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
- Mitochondrial Trifunctional Protein Deficiency